FR2909099B1 - Methode de diagnostic et de suivi d'une vaginose bacterienne par quantification moleculaire. - Google Patents

Methode de diagnostic et de suivi d'une vaginose bacterienne par quantification moleculaire.

Info

Publication number
FR2909099B1
FR2909099B1 FR0610313A FR0610313A FR2909099B1 FR 2909099 B1 FR2909099 B1 FR 2909099B1 FR 0610313 A FR0610313 A FR 0610313A FR 0610313 A FR0610313 A FR 0610313A FR 2909099 B1 FR2909099 B1 FR 2909099B1
Authority
FR
France
Prior art keywords
bacterial vaginosis
diagnosing
dna
copies
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0610313A
Other languages
English (en)
French (fr)
Other versions
FR2909099A1 (fr
Inventor
Florence Bretelle
Florence Fenollar
Mary Mireille Henry
Jean Pierre Menard
Didier Raoult
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aix-Marseille Université
Original Assignee
Universite de la Mediterranee Aix Marseille II
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0610313A priority Critical patent/FR2909099B1/fr
Application filed by Universite de la Mediterranee Aix Marseille II filed Critical Universite de la Mediterranee Aix Marseille II
Priority to PCT/FR2007/052368 priority patent/WO2008062136A2/fr
Priority to ES07866534T priority patent/ES2371202T3/es
Priority to JP2009537684A priority patent/JP2010509932A/ja
Priority to AT07866534T priority patent/ATE519865T1/de
Priority to EP07866534A priority patent/EP2087134B1/fr
Priority to US12/312,711 priority patent/US20100075306A1/en
Publication of FR2909099A1 publication Critical patent/FR2909099A1/fr
Application granted granted Critical
Publication of FR2909099B1 publication Critical patent/FR2909099B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR0610313A 2006-11-24 2006-11-24 Methode de diagnostic et de suivi d'une vaginose bacterienne par quantification moleculaire. Expired - Fee Related FR2909099B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0610313A FR2909099B1 (fr) 2006-11-24 2006-11-24 Methode de diagnostic et de suivi d'une vaginose bacterienne par quantification moleculaire.
ES07866534T ES2371202T3 (es) 2006-11-24 2007-11-20 Método de diagnóstico y de seguimiento de una vaginosis bacteriana mediante cuantificación molecular.
JP2009537684A JP2010509932A (ja) 2006-11-24 2007-11-20 分子レベルの定量による細菌性膣炎の診断および追跡調査の方法
AT07866534T ATE519865T1 (de) 2006-11-24 2007-11-20 Verfahren zur diagnose und verfolgung von bakterieller vaginose mittels molekularer quantifizierung
PCT/FR2007/052368 WO2008062136A2 (fr) 2006-11-24 2007-11-20 Methode de diagnostic et de suivi d'une vaginose bacterienne par quantification moleculaire
EP07866534A EP2087134B1 (fr) 2006-11-24 2007-11-20 Methode de diagnostic et de suivi d'une vaginose bacterienne par quantification moleculaire
US12/312,711 US20100075306A1 (en) 2006-11-24 2007-11-20 Method for diagnosis of and following a bacterial vaginosis by molecular quantification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0610313A FR2909099B1 (fr) 2006-11-24 2006-11-24 Methode de diagnostic et de suivi d'une vaginose bacterienne par quantification moleculaire.

Publications (2)

Publication Number Publication Date
FR2909099A1 FR2909099A1 (fr) 2008-05-30
FR2909099B1 true FR2909099B1 (fr) 2012-10-19

Family

ID=38229508

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0610313A Expired - Fee Related FR2909099B1 (fr) 2006-11-24 2006-11-24 Methode de diagnostic et de suivi d'une vaginose bacterienne par quantification moleculaire.

Country Status (7)

Country Link
US (1) US20100075306A1 (enExample)
EP (1) EP2087134B1 (enExample)
JP (1) JP2010509932A (enExample)
AT (1) ATE519865T1 (enExample)
ES (1) ES2371202T3 (enExample)
FR (1) FR2909099B1 (enExample)
WO (1) WO2008062136A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5593037B2 (ja) * 2009-03-12 2014-09-17 東洋水産株式会社 細菌測定用プライマーおよび細菌測定方法
CN102770559B (zh) * 2009-12-03 2015-11-25 奎斯特诊断投资有限公司 诊断细菌性阴道炎的方法
EP3040425B1 (en) * 2010-02-17 2019-08-28 Gen-Probe Incorporated Compostions and methods to detect atopobium vaginae nucleic acid
CA2816311C (en) 2010-11-01 2018-07-17 Becton, Dickinson And Company Gardnerella vaginalis assay
AU2012304327B2 (en) * 2011-09-08 2015-07-09 Gen-Probe Incorporated Compositions and methods for detecting BV-associated bacterial nucleic acid
US9970060B2 (en) * 2011-11-23 2018-05-15 Medical Diagnostic Laboratories, Llc Quantitation and profiling of vaginal microflora
US9057111B2 (en) 2012-02-20 2015-06-16 Laboratory Corporation Of America Holdings Diagnostic methods and markers for bacterial vaginosis
PL228161B1 (pl) 2013-05-21 2018-02-28 Univ Jagiellonski Sposób jednoczesnej detekcji bakterii i grzybów w preparacie biologicznym metoda PCR oraz zestaw do detekcji bakterii i grzybów w preparacie biologicznym metoda PCR
JP6383552B2 (ja) * 2014-03-27 2018-08-29 三菱重工業株式会社 スフィンゴモナス属細菌の検出方法及びそのプライマー、生物処理槽の活性予測方法
EA025042B1 (ru) * 2014-06-03 2016-11-30 Общество с ограниченной ответственностью "ИнтерЛабСервис" Способ дифференциальной диагностики нарушений баланса вагинальной микрофлоры
AU2016233298B2 (en) 2015-03-16 2021-09-02 Gen-Probe Incorporated Methods and compositions for detecting bacterial nucleic acid and diagnosing bacterial vaginosis
WO2016172204A1 (en) 2015-04-24 2016-10-27 Becton, Dickinson And Company Multiplex detection of vulvovaginal candidiasis, trichomoniasis and bacterial vaginosis
PL235777B1 (pl) 2015-07-10 2020-10-19 Univ Jagiellonski Startery, sposób i zestaw diagnostyczny do diagnozowania sepsy
KR101739749B1 (ko) 2015-11-24 2017-05-25 윤현규 리얼타임 ｐｃｒ을 이용한 질염 검사 키트 및 방법
FR3075224B1 (fr) * 2017-12-18 2022-06-17 Fond Mediterranee Infection Methode de diagnostic d'une vaginose bacterienne par detection de methanobrevibacter smithii
RU2670206C1 (ru) * 2017-12-26 2018-10-19 Общество с ограниченной ответственностью "НекстБио" Набор синтетических олигонуклеотидов для выявления ДНК Atopobium vaginae в слизистой оболочке влагалища
RU2670280C1 (ru) * 2017-12-26 2018-10-22 Общество с ограниченной ответственностью "НекстБио" Набор синтетических олигонуклеотидов для выявления ДНК Lactobacillus spp. в слизистой оболочке влагалища
RU2670207C1 (ru) * 2017-12-26 2018-10-19 ООО "НекстБио" Набор синтетических олигонуклеотидов для выявления ДНК Gardnerella vaginalis в слизистой оболочке влагалища
CA3099513A1 (en) * 2018-05-22 2019-11-28 Artpred B.V. Method and kit for predicting the outcome of an assisted reproductive technology procedure
CN114341365A (zh) * 2019-08-30 2022-04-12 詹森生物科技公司 B细胞成熟复合物car t构建体和引物
US20220205020A1 (en) * 2020-12-30 2022-06-30 Roche Molecular Systems, Inc. Compositions and methods for detection of bacteria and fungi associated with bacterial and candida vaginosis
CN114480694B (zh) * 2022-04-18 2022-06-17 北京起源聚禾生物科技有限公司 阴道微生态检测引物探针组合及试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050095603A1 (en) * 2003-11-05 2005-05-05 Cepheid Universal control for nucleic acid amplification
RU2420595C2 (ru) * 2005-01-31 2011-06-10 Кабусики Кайся Якулт Хонса СПОСОБ КОЛИЧЕСТВЕННОГО АНАЛИЗА КОЛИЧЕСТВА КЛЕТОК ПРЕДСТАВЛЯЮЩЕЙ ИНТЕРЕС БАКТЕРИИ В ЖИВОМ СОСТОЯНИИ С ПРИМЕНЕНИЕМ рРНК В КАЧЕСТВЕ МИШЕНИ
US7625704B2 (en) * 2005-08-31 2009-12-01 Fred Hutchinson Cancer Research Center Methods and compositions for identifying bacteria associated with bacteria vaginosis

Also Published As

Publication number Publication date
WO2008062136A3 (fr) 2008-07-10
JP2010509932A (ja) 2010-04-02
WO2008062136A2 (fr) 2008-05-29
FR2909099A1 (fr) 2008-05-30
ATE519865T1 (de) 2011-08-15
US20100075306A1 (en) 2010-03-25
ES2371202T3 (es) 2011-12-28
WO2008062136A9 (fr) 2009-07-16
EP2087134A2 (fr) 2009-08-12
EP2087134B1 (fr) 2011-08-10

Similar Documents

Publication Publication Date Title
ATE519865T1 (de) Verfahren zur diagnose und verfolgung von bakterieller vaginose mittels molekularer quantifizierung
O’Callaghan et al. Re‐assessing microbiomes in the low‐biomass reproductive niche
Hajishengallis et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement
Aïm et al. Efficacy of arthroscopic treatment for resolving infection in septic arthritis of native joints
Roychowdhury et al. Faecalibacterium prausnitzii and a prebiotic protect intestinal health in a mouse model of antibiotic and Clostridium difficile exposure
Dias et al. Changes in mouse gut bacterial community in response to different types of drinking water
Dunyach-Remy et al. Link between nasal carriage of Staphylococcus aureus and infected diabetic foot ulcers
Hajjar et al. Current evidence on the relation between gut microbiota and intestinal anastomotic leak in colorectal surgery
Berlamont et al. Antimicrobial susceptibility pattern of Helicobacter suis isolates from pigs and macaques
MX2021000069A (es) Composiciones y metodos para tratar la enfermedad intestinal inflamatoria.
Gilbertie et al. Comprehensive phenotypic and genotypic characterization and comparison of virulence, biofilm, and antimicrobial resistance in urinary Escherichia coli isolated from canines
Michalik et al. Intra-operative biopsy in chronic sinusitis detects pathogenic Escherichia coli that carry fimG/H, fyuA and agn43 genes coding biofilm formation
Chen et al. The importance of matrix-assisted laser desorption ionization–time of flight mass spectrometry for correct identification of Clostridium difficile isolated from chromID C. difficile chromogenic agar
Wang et al. Multiplex PCR system for the diagnosis of plague
Liang et al. Coinfection of SARS-CoV-2 and influenza a (H3N2) detected in bronchoalveolar lavage fluid of a patient with long COVID using metagenomic next− generation sequencing: A case report
Wang et al. Association of coagulase-negative staphylococci with orthopedic infections detected by in-house multiplex real-time PCR
BR112022022045A2 (pt) Anticorpo ou fragmento de ligação ao antígeno do mesmo que se liga ao cd103 humano, um ou mais ácidos nucleicos, sistema de expressão, célula hospedeira, composição, métodos de produção de um anticorpo ou fragmento de ligação ao antígeno, para detectar a presença de cd103 em uma amostra biológica, para tratar ou prevenir uma condição mediada por sinalização de cd103 em um indivíduo em necessidade, para inibir a sinalização de cd103 em uma célula, para inibir a ligação de cd103 à e-caderina presente em uma célula, para retirar as células que expressam cd103 em um indivíduo, para tratar ou prevenir uma doença e agente de imageamento
Tsai et al. Markedly elevated soluble E-cadherin in plasma of patient with pelvic inflammatory disease
Ramirez Finn et al. How Does Biological Sex Impact Mucosal Bacterial Infection? Mucosal Defenses and Bacterial Detection
Walk et al. Non-toxigenic Clostridium sordellii: clinical and microbiological features of a case of cholangitis-associated bacteremia
Liu et al. Inhibition of FOSL1 alleviates inflammatory injury of otitis media by reducing ferroptosis
ES2530866T3 (es) Marcador temprano de proteinuria en pacientes tratados con un tratamiento anti-VEGF
Li et al. Antibiofilm activity of arachidonic acid against linezolid-resistant Enterococcus faecalis: A potential strategy for combating biofilm-related infections
Hai et al. Extraintestinal Clostridioides difficile infection
Yeh et al. Significantly increased concentration of soluble urokinase-type plasminogen activator receptor in the blood of patients with pelvic inflammatory disease

Legal Events

Date Code Title Description
TP Transmission of property

Owner name: UNIVERSITE D'AIX-MARSEILLE, FR

Effective date: 20140220

PLFP Fee payment

Year of fee payment: 10

ST Notification of lapse

Effective date: 20170731